Key result
In vitro testing of the newly developed Thoratec TLC-II Portable VAD Driver demonstrated the ability to pump VAD outputs up to 7 L/min.
The development of a portable pneumatic biventricular driver capable of pumping up to 7 L/min in vitro may enhance mobility and quality of life for VAD patients.
No takes yet. Share an insight, caveat, or question.
In vitro success of portable VAD driver encourages development; leaves open clinical translation and patient benefit.
Farrar et al. (1997) studied Heart failure requiring ventricular assist device. Thoratec TLC-II Portable VAD Driver was evaluated on VAD output (in vitro). In vitro testing of the newly developed Thoratec TLC-II Portable VAD Driver demonstrated the ability to pump VAD outputs up to 7 L/min.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: